Research
Hormonal
Dual and triple agonists show effectiveness on validated surrogate NAFLD biomarkers.
There is potential for dual and triple agonists to be effective in treating NAFLD, warranting further investigation.
StrongSupportsmedium confidence
Both dual and triple agonists are promising, based on animal, pharmacokinetic and proof-of concept studies, showing effectiveness... on a few validated surrogate NAFLD biomarkers.
Why this rating
The claim is based on a review of various studies.
Source
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes
Lucia Brodosi et al. · Expert Opinion on Pharmacotherapy · 2023
reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →